Search results
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 3 months agoRegeneron Pharmaceuticals (NASDAQ:REGN) has had a great run on the share market with its stock up by...
Are Strong Financial Prospects The Force That Is Driving The Momentum In Regeneron Pharmaceuticals,...
Simply Wall St. via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals (NASDAQ:REGN) has had a great run on the share market with its stock up by...
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock...
Simply Wall St. via Yahoo Finance· 1 week agoKey Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have...
Are Robust Financials Driving The Recent Rally In Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN)...
Simply Wall St. via Yahoo Finance· 9 months agoMost readers would already be aware that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased...
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...
Simply Wall St. via Yahoo Finance· 2 weeks agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Declining Stock and Solid Fundamentals: Is The Market Wrong About Regeneron Pharmaceuticals, Inc....
Simply Wall St. via Yahoo Finance· 1 year agoIt is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent...
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Latest Stock Performance Being Led By Its Strong...
Simply Wall St. via Yahoo Finance· 4 months agoMost readers would already know that Regeneron Pharmaceuticals' (NASDAQ:REGN) stock increased by...
Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
Investor's Business Daily· 1 year agoSanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...
Regeneron Slumps As Its Biggest Moneymaker Flops Amid Ongoing Roche Rivalry
Investor's Business Daily· 4 months agoSales of Regeneron Pharmaceuticals' biggest moneymaker, Eylea, disappointed on Monday amid continued...